#advm

3 months ago

#ADVM Adverum Reminds Stockholders to Tender their Shares into the Offer by Lilly

www.stocktitan.net/news/ADVM/adverum-remind...

0 0 0 0

Halper Sadeh LLC Urges Shareholders of ADVM, PLYM, and RNA to Assert Their Rights Halper Sadeh LLC is investigating several corporations, including ADVM, PLYM, and RNA, for possible violations of federal securities laws. Shareholders are urged to act quickly to protect their rights.

4 months ago

Halper Sadeh LLC Urges Shareholders of ADVM, PLYM, and RNA to Assert Their Rights #United_States #New_York #Halper_Sadeh #ADVM #RNA

0 0 0 0

Lilly to Acquire Adverum Biotechnologies Eli Lilly (NYSE:LLY) agreed to acquire Adverum Biotechnologies for $3.56 cash per share plus one CVR, with the CVR payable up to $8.91 for total potential consideration of $12.47 per share. The deal funds a tender offer and a second-step merger, is expected to close in Q4 2025, and requires a majority tender. Lilly provided a secured $65 million promissory note to support Adverum operations pre-close. Adverum's lead asset, Ixo-vec, is a Phase 3 intravitreal gene therapy for wet AMD (ARTEMIS trial completed screening) with Fast Track, RMAT, EMA PRIME, and UK Innovation Passport designations.

4 months ago

#LLY #ADVM Lilly to Acquire Adverum Biotechnologies

www.stocktitan.net/news/LLY/lilly-to-acquir...

0 0 0 0

Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights Adverum Biotechnologies (Nasdaq: ADVM) reported significant progress in its ARTEMIS Phase 3 trial for wet AMD treatment, with enrollment exceeding expectations and completion anticipated in Q1 2026. The company secured a $10 million private placement from Frazier Life Sciences.Key highlights include: upcoming LUNA 2-year follow-up data in Q4 2025, strong retina specialist enthusiasm for gene therapy (preferred by 50% of specialists), and anticipated ARTEMIS topline data in 1H 2027. Financial results show $44.4 million in cash as of June 30, 2025, with a net loss of $49.2 million ($2.34 per share) for Q2 2025. [ "Strong enrollment progress in ARTEMIS Phase 3 trial, ahead of schedule", "Secured $10 million private placement from Frazier Life Sciences", "50% of retina specialists view gene therapy as most exciting advancement in wet AMD treatment", "Potential for Ixo-vec to offer lifelong, best-in-class therapy for wet AMD" ]

7 months ago

#ADVM Adverum Biotechnologies Reports Second Quarter 2025 Financial Results and Provides Pipeline Highlights

www.stocktitan.net/news/ADVM/adverum-biotec...

0 0 0 0

Revolutionary One-Time Gene Therapy Shows 3.5-Year Vision Protection in Wet AMD Patients Adverum's groundbreaking gene therapy trial begins as Q1 losses widen to $47M. New data shows 3.5-year vision protection after single treatment. Get full insights.

10 months ago

#ADVM Adverum Biotechnologies Reports First Quarter 2025 Financial Results and Provides Pipeline Highlights

www.stocktitan.net/news/ADVM/adverum-biotec...

0 0 0 0

Investigation into Alleged Securities Fraud by Adverum Biotechnologies, Inc. Raises Red Flags for Investors Pomerantz Law Firm is probing potential securities fraud involving Adverum Biotechnologies, Inc. due to irregularities in financial statements.

10 months ago

Investigation into Alleged Securities Fraud by Adverum Biotechnologies, Inc. Raises Red Flags for Investors #United_States #New_York #Pomerantz_Law_Firm #Adverum_Biotechnologies #ADVM

0 0 0 0

Pomerantz Law Firm Investigates Potential Fraud Claims Against Adverum Biotechnologies Inc. Pomerantz Law Firm is conducting an investigation into possible securities fraud by Adverum Biotechnologies. Interested investors are encouraged to reach out for more details.

10 months ago

Pomerantz Law Firm Investigates Potential Fraud Claims Against Adverum Biotechnologies Inc. #USA #New_York #Pomerantz_LLP #Adverum_Biotechnologies #ADVM

0 0 0 0

Small Cap Strategist

@smcapstrategist.bsky.social

10 months ago

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with declining money flow, Wed Apr 16th - #WNW #TRST #QRHC #WTI #SHCO #NVRO #MAX #KLC #FRGE #DTC #ZD #VREX #SCLX #ADVM #CADL #DOYU #GREE #IMTX #KIDS #PDLB - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 2 0

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones Adverum Biotechnologies (ADVM) has reported its Q4 and full year 2024 financial results, highlighting significant progress with its Ixo-vec gene therapy for wet AMD treatment. The company has initiated ARTEMIS, their first pivotal trial, which will evaluate Ixo-vec in approximately 284 patients.The company's cash position stood at $125.7 million as of December 31, 2024, expected to fund operations into H2 2025. Q4 2024 resulted in a net loss of $40.9 million ($1.96 per share), compared to $24.5 million in Q4 2023. R&D expenses increased to $24.1 million from $15.3 million, while G&A expenses rose to $18.5 million from $11.7 million year-over-year.Key upcoming milestones include the initiation of the global AQUARIUS Phase 3 trial in H2 2025 and presentation of Phase 2 LUNA two-year follow-up data in Q4 2025.

10 months ago

#ADVM Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

www.stocktitan.net/news/ADVM/adverum-biotec...

0 0 0 0

Pomerantz Law Firm Launches Investigation on Adverum Biotechnologies for Alleged Securities Fraud Pomerantz LLP is investigating potential securities fraud claims against Adverum Biotechnologies, impacting investors significantly. Join the inquiry.

11 months ago

Pomerantz Law Firm Launches Investigation on Adverum Biotechnologies for Alleged Securities Fraud #United_States #New_York #Pomerantz_LLP #Adverum_Biotechnologies #ADVM

0 0 0 0

Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD Adverum Biotechnologies (Nasdaq: ADVM) has initiated ARTEMIS, a pioneering Phase 3 study evaluating Ixo-vec, a one-time gene therapy for wet AMD. The US-based trial will assess a single Ixo-vec injection versus aflibercept in 284 patients, including both treatment-naïve and previously treated individuals.The study's primary endpoint measures change in best corrected visual acuity at one year, with a non-inferiority margin of -4.5 letters. ARTEMIS is the first of two planned Phase 3 registrational trials, with the second study (AQUARIUS) to be conducted globally.Key trial design features include:Single administration of Ixo-vec (6E10 vg/eye) compared to aflibercept (2mg) every 8 weeksThree loading doses of aflibercept prior to Ixo-vec administrationEligibility for supplemental aflibercept injectionsProphylactic steroid eye drops for all patients

1 year ago

#ADVM Adverum Biotechnologies Initiates ARTEMIS Phase 3 Study Evaluating Ixo-vec for Wet AMD

www.stocktitan.net/news/ADVM/adverum-biotec...

0 0 0 0

DionyZack 🍉✊🏽♀️🌿

@dionyzack.bsky.social

1 year ago

Une loterie solidaire lancée par le rappeur ADVM en soutien aux mineurs de la Gaîté Lyrique À l’initiative de l’artiste ADVM, en collaboration avec l’entreprise Featuring, une loterie solidaire a été mise en place, mardi 18 février. Les fonds serviront à soutenir les 400 mineurs exilés occupant les locaux de la Gaîté Lyrique. Une action motivée…

🅱️🅱️ BondyBlog 🅱️🅱️ Une loterie solidaire lancée par le rappeur ADVM en soutien aux mineurs de la Gaîté Lyrique: À l’initiative de l’artiste ADVM, en collaboration avec l’entreprise Featuring, une loterie solidaire a été mise en… #LoterieSolidaire #ADVM #GaîtéLyrique #MineursExilés #ActionSociale

2 1 1 0

Spanish open dictionary

@wordmeaningdic.bsky.social

1 year ago

Meaning of #advm Abbreviation for adverb male... adv m

0 0 0 0

Diccionario Abierto

@significadode.bsky.social

1 year ago

Significado de #advm Abreviatura de Adverbio masculino... adv m

0 0 0 0

Dicionário colaborativo Espanhol

@ptsignificadode.bsky.social

1 year ago

Significado de #advm Abreviatura de macho de advérbio... adv m

0 0 0 0

1 year ago

#ADVM Adverum Biotechnologies Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

www.stocktitan.net/news/ADVM/adverum-biotec...

0 0 0 0

1 year ago

#ADVM Adverum Biotechnologies Announces Positive 52-Week LUNA and 4-Year OPTIC Results, and Provides Key Pivotal Program Design Elements

www.stocktitan.net/news/ADVM/adverum-biotec...

0 0 0 0